Today’s news items are focused on issues affecting risk for prostate cancer and risk for progression after treatment, and the ways these risks can be affected by available data:
- Does the regular use of NSAIDs affect risk for prostate cancer, or just affect PSA levels?
- Do prostate size and intensity of biopsy sampling impact risk for Gleason sum upgrading post-surgery?
- Are there other specific factors that affect risk for Gleason sum upgrading (or downgrading) post-surgery?
- How do other factors discovered at the time of surgery that affect risk for biochemical progression? … READ MORE …
Filed under: Diagnosis, Management, Prevention, Treatment | Tagged: downgrading, Gleason, NSAID, pathological, risk, score, upgrading | Leave a comment »